Litcius/Paper detail

Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression

Yanyan Zhang, Charles Wang, Jian Jian Li

2024Experimental Hematology and Oncology24 citationsDOIOpen Access PDF

Abstract

Immune checkpoint blockade (ICB) necessitates a thorough understanding of intricate cellular interactions within the tumor microenvironment (TME). Mesenchymal stromal cells (MSCs) play a pivotal role in cancer generation, progression, and immunosuppressive tumor microenvironment. Within the TME, MSCs encompass both resident and circulating counterparts that dynamically communicate and actively participate in TME immunosurveillance and response to ICB. This review aims to reevaluate various facets of MSCs, including their potential self-transformation to function as cancer-initiating cells and contributions to the creation of a conducive environment for tumor proliferation and metastasis. Additionally, we explore the immune regulatory functions of tumor-associated MSCs (TA-MSCs) and MSC-derived extracellular vesicles (MSC-EVs) with analysis of potential connections between circulating and tissue-resident MSCs. A comprehensive understanding of the dynamics of MSC-immune cell communication and the heterogeneous cargo of tumor-educated versus naïve MSCs may unveil a new MSC-mediated immunosuppressive pathway that can be targeted to enhance cancer control by ICB.

Topics & Concepts

ImmunosurveillanceMesenchymal stem cellTumor microenvironmentStromal cellImmune systemMetastasisCancer researchImmunosuppressionCancerBiologyImmune checkpointImmunotherapyImmunologyMedicineCell biologyInternal medicineExtracellular vesicles in diseaseImmune cells in cancerCancer Immunotherapy and Biomarkers
Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression | Litcius